Seminars in Oncology
Volume 30, Issue 1 , Pages 1-2 , February 2003

Introduction: Small cell lung cancer—A frustrating disease

References 

  1. Sierocki JS, Hilaris BS, Hopfan S, et al.  Cis-dichlorodiamineplatinum (II) and VP-16-213: An active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep. 1979;63:1593–1597
  2. Noda K, Nishiwaki Y, Kawahara M, et al.  Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med. 2002;346:85–91
  3. Pignon JP, Arriagada R, Ihde DC, et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618–1624
  4. Turrisi AT, Kim K, Blum R, et al.  Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265–271
  5. Auperin A, Arriagada R, Pignon J-P, et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;341:476–484
  6. Page NC, Read WL, Tierney RM, et al.  The epidemiology of small cell lung carcinoma. Proc Am Soc Clin Oncol. 2002;21:305a; (abstr 1216)

PII: S0093-7754(03)70037-2

doi: 10.1053/sonc.2003.50011

Seminars in Oncology
Volume 30, Issue 1 , Pages 1-2 , February 2003

Article Tools